Wolverine Trading
AGIO icon

Wolverine Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Wolverine Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,300
Closed -$333K – 5186
2024
Q3 		$333K Buy
+7,300
New +$332K ﹤0.01% 3493
2024
Q2 		– Sell
-10,900
Closed -$319K – 4393
2024
Q1 		$319K Buy
+10,900
New +$292K ﹤0.01% 3291
2022
Q4 		– Sell
-7,800
Closed -$223K – 3875
2022
Q3 		$223K Buy
+7,800
New +$209K ﹤0.01% 3477
2021
Q4 		– Sell
-5,400
Closed -$250K – 5633
2021
Q3 		$250K Buy
+5,400
New +$261K ﹤0.01% 4988
2021
Q2 		– Sell
-7,500
Closed -$369K – 5786
2021
Q1 		$369K Sell
7,500
-11,500
-61% -$570K ﹤0.01% 4167
2020
Q4 		$846K Buy
19,000
+10,800
+132% +$427K ﹤0.01% 2576
2020
Q3 		$282K Sell
8,200
-4,200
-34% -$184K ﹤0.01% 3466
2020
Q2 		$657K Sell
12,400
-7,900
-39% -$366K ﹤0.01% 2438
2020
Q1 		$719K Buy
+20,300
New +$938K ﹤0.01% 2261
2019
Q4 		– Sell
-19,500
Closed -$672K – 4589
2019
Q3 		$672K Buy
19,500
+1,600
+9% +$66.2K ﹤0.01% 2316
2019
Q2 		$893K Sell
17,900
-8,200
-31% -$438K ﹤0.01% 2152
2019
Q1 		$1.76M Buy
26,100
+2,400
+10% +$140K 0.01% 1636
2018
Q4 		$1.07M Buy
+23,700
New +$1.46M ﹤0.01% 1898
2017
Q3 		– Sell
-14,400
Closed -$755K – 4349
2017
Q2 		$755K Buy
14,400
+2,600
+22% +$133K ﹤0.01% 2019
2017
Q1 		$677K Buy
+11,800
New +$566K ﹤0.01% 2071

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wolverine Trading's AGIO Position: Q1 2021 in Review

Wolverine Trading sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 4,945 shares — an estimated $245K sold.

Wolverine Trading first reported a position in AGIO in Q2 2017 and held it in 4 quarters. The position peaked at $341K in Q2 2019. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Wolverine Trading reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 4,945 Agios Pharmaceuticals shares in Q1 2021, an estimated $245K.
  • Wolverine Trading first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Wolverine Trading's Agios Pharmaceuticals position peaked at $341K in Q2 2019.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.